Information on Curcumin (Turmeric)

Curcumin is extracted from the roots of a plant - turmeric, which is native to India. It is a common culinary spice, that gives curry powder its distinctive yellow color.

Curcumin (Turmeric) Benefits

Curcumin is a powerful antioxidant, anti-inflammatory and anti-hepatotoxic (good for the liver) herb. It reduces the free radical damage inflicted on smokers by the harmful chemicals in cigarettes. It also may reduce inflammation from rheumatoid arthritis, inhibit the growth of cancer cells, protect the liver from toxins, help to dissolve gallstones, lower cholesterol levels, alleviate joint swellings, increase joint flexibility and reduce menstrual pain.

Turmeric, has long been used in India as an ayurvedic medicine to strengthen liver function. Turmeric also helps prevent the formation of blood clots that can lead to heart attack. It is not only used to season foods but also as a food preservative and coloring agent.

Curcumin Supplements

As a supplement, one to three 500 mg curcumin capsules daily with food is the suggested dosage. Many commercial preparations combine curcumin with bromelain which is an another anti-inflammatory. Both of them work best together and bromelain may increase the absorption of curcumin.

Leave your comments

Health News

Surgeon Removes Eight Pound Liver Tumor

The cancerous tumor in Marcus Muhich's liver weighed 8 pounds and was nearly a foot across. Doctors at three major academic medical centers in the Midwest told Muhich his high-grade tumor was inoperable. Then he was referred to Dr... [ read article ]

NIPPV Linked To Increased Hospital Mortality Rates In Small Group Of Patients

Although increased use of noninvasive positive-pressure ventilation (NIPPV) nationwide has helped decrease mortality rates among patients hospitalized with chronic obstructive pulmonary disease (COPD), a small group of... [ read article ]

FDA Approves Label Update For PREZISTA® To Include 192-Week Data In HIV-1-Infected Adult Patients

Starting Treatment Janssen Therapeutics, Division of Janssen Products, LP, announced that the U.S. Food and Drug Administration (FDA) has approved a label update for PREZISTA® (darunavir) tablets to include 192-week data from the ARTEMIS study... [ read article ]

Recommended Stuff

Our Latest Blog Entries...